Sun Pharmaceutical Industries Ltd. closed 8.84% short of its 52-week high of 1,960.20 rupees, which the company reached on ...

Sun Pharmaceutical Industries Ltd. closed 7.94% short of its 52-week high of 1,960.20 rupees, which the company achieved on ...

NEW DELHI: Drug makers Glenmark, Sun Pharma and Zydus are recalling products in the US for manufacturing issues, the US Food and Drug Administration (USFDA) said in its latest Enforcement Report.

Sun Pharma said it will disclose its launch plans in due course of time. Leqselvi or deuruxolitinib is used to treat alopecia areata, an auto-immune condition that causes hair-loss, and it affects ...

The injunction had temporarily barred Sun Pharma from launching Leqselvi in the United States due to an ongoing legal battle with Incyte Corporation. The appellate court's decision, which came shortly ...

Pharma stocks such as Sun Pharma, Aurobindo Pharma, Dr Reddy's Lab, Cipla, Gland Pharma, Zydus Lifesciences and Lupin would be in action on Friday after the US President Donald Trump halted ...

Indian pharma stocks, including Sun Pharmaceutical Industries, Gland Pharma, Lupin and others traded sharply lower on Wednesday after the US President Donald Trump said he will soon announce a ...

Aurobindo Pharma followed with a 9.4 per cent rally, while Dr Reddy’s Laboratories surged 7 per cent to Rs 1,226.9. Lupin also gained nearly 7 per cent, touching Rs 2,149.2. Other notable gainers ...

Sun Pharma shares dipped in the intraday trading session on Friday, March 28. The Indian equity markets are in a tight spot, as they have vacillated from lows to highs and greens and reds in today ...

In the latest raid which happened last week at Second Bazar in Secunderabad, the officials seized counterfeit versions of ‘Montek-LC tablets (montelukast sodium and levocetirizine hydrochloride ...

Ajanta Pharma, Granules India, and Sun Pharmaceutical also traded with losses, ranging between 2% and 4%. Uncertainty surrounding the scale of US tariffs, the possibility of retaliatory measures ...